Posted in Business NewsData Presented from Two Phase 3 ERBITUX® Studies in First-Line Metastatic Colorectal Cancer Patients at Joint 15th European Cancer Organisation and 34th European Society for Medical Oncology Multidisciplinary Congress Editor September 23, 2009 Please leave this field emptyGet every new post delivered right to your inbox.Email *Check your inbox or spam folder to confirm your subscription.Original Source